Abstract
3,4-Methylenedioxypyrovalerone (MDPV) is consumed worldwide, despite its potential to cause toxicity in several organs and even death. There is a recognized need to clarify the biological pathways through which MDPV elicits general and target-organ toxicity. In this work, a comprehensive untargeted GC–MS-based metabolomics analysis was performed, aiming to detect metabolic changes in putative target organs (brain, heart, kidneys and liver) but also in urine of mice after acute exposure to human-relevant doses of MDPV. Male CD-1 mice received binge intraperitoneal administrations of saline or MDPV (2.5 mg/kg or 5 mg/kg) every 2 h, for a total of three injections. Twenty-four hours after the first administration, target organs, urine and blood samples were collected for metabolomics, biochemical and histological analysis. Hepatic and renal tissues of MDPV-treated mice showed moderate histopathological changes but no significant differences were found in plasma and tissue biochemical markers of organ injury. In contrast, the multivariate analysis significantly discriminated the organs and urine of MDPV-treated mice from the control (except for the lowest dose in the brain), allowing the identification of a panoply of metabolites. Those levels were significantly deviated in relation to physiological conditions and showed an organ specific response towards the drug. Kidneys and liver showed the greatest metabolic changes. Metabolites related with energetic metabolism, antioxidant defenses and inflammatory response were significantly changed in the liver of MDPV-dosed animals, while the kidneys seem to have developed an adaptive response against oxidative stress caused by MDPV. On the other hand, the dysregulation of metabolites that contribute to metabolic acidosis was also observed in this organ. The heart showed an increase of fatty acid biosynthesis, possibly as an adaptation to maintain the cardiac energy homeostasis. In the brain, changes in 3-hydroxybutyric acid levels may reflect the activation of a neurotoxic pathway. However, the increase in metabolites with neuroprotective properties seems to counteract this change. Metabolic profiling of urine from MDPV-treated mice suggested that glutathione-dependent antioxidant pathways may be particularly involved in the compensatory mechanism to counteract oxidative stress induced by MDPV. Overall, this study reports, for the first time, the metabolic profile of liver, kidneys, heart, brain, and urine of MDPV-dosed mice, providing unique insights into the biological pathways of toxicity. Our findings also underline the value of toxicometabolomics as a robust and sensitive tool for detecting adaptive/toxic cellular responses upon exposure to a physiologically relevant dose of a toxic agent, earlier than conventional toxicity tests.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akbari A, Jelodar G, Nazifi S, Sajedianfard J (2016) An overview of the characteristics and functions of vitamin C in various tissues: relying on its antioxidant function. Zahedan J Res Med Sci 18(11):e4037. https://doi.org/10.17795/zjrms-4037
Araujo AM, Bastos ML, Carvalho F, Guedes de Pinho P, Carvalho M (2020) Effect of temperature on 3,4-Methylenedioxypyrovalerone (MDPV)-induced metabolome disruption in primary mouse hepatic cells. Toxicology 441:152503. https://doi.org/10.1016/j.tox.2020.152503
Battelli MG, Polito L, Bortolotti M, Bolognesi A (2016) Xanthine oxidoreductase in drug metabolism: beyond a role as a detoxifying enzyme. Curr Med Chem 23(35):4027–4036. https://doi.org/10.2174/0929867323666160725091915
Baumann MH, Bukhari MO, Lehner KR et al (2017) Neuropharmacology of 3,4-methylenedioxypyrovalerone (MDPV), its metabolites, and related analogs. Curr Top Behav Neurosci 32:93–117. https://doi.org/10.1007/7854_2016_53
Beck BD, Seely M, Calabrese EJ (2014) The use of toxicology in the regulatory process. In: Wallace Hayes A, Kruger CL (eds) Haye’s principles and methods of toxicology, 6th edn. CRC Press, Boca Raton, pp 35–87
Beger RD (2013) A review of applications of metabolomics in cancer. Metabolites 3(3):552–574. https://doi.org/10.3390/metabo3030552
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57(1):289–300
Benowitz LI, Jing Y, Tabibiazar R et al (1998) Axon outgrowth is regulated by an intracellular purine-sensitive mechanism in retinal ganglion cells. J Biol Chem 273(45):29626–29634. https://doi.org/10.1074/jbc.273.45.29626
Benowitz LI, Goldberg DE, Madsen JR, Soni D, Irwin N (1999) Inosine stimulates extensive axon collateral growth in the rat corticospinal tract after injury. Proc Natl Acad Sci USA 96(23):13486–13490. https://doi.org/10.1073/pnas.96.23.13486
Berben L, Sereika SM, Engberg S (2012) Effect size estimation: methods and examples. Int J Nurs Stud 49(8):1039–1047. https://doi.org/10.1016/j.ijnurstu.2012.01.015
Borek HA, Holstege CP (2012) Hyperthermia and multiorgan failure after abuse of “bath salts” containing 3,4-methylenedioxypyrovalerone. Ann Emerg Med 60(1):103–105. https://doi.org/10.1016/j.annemergmed.2012.01.005
Bouhifd M, Hartung T, Hogberg HT, Kleensang A, Zhao L (2013) Review: toxicometabolomics. J Appl Toxicol 33(12):1365–1383. https://doi.org/10.1002/jat.2874
Brereton RG, Lloyd GR (2014) Partial least squares discriminant analysis: taking the magic away. J Chemom 28:213–225. https://doi.org/10.1002/cem.2609
Broadhurst D, Goodacre R, Reinke SN et al (2018) Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics 14(6):72. https://doi.org/10.1007/s11306-018-1367-3
Cahill GF Jr (2006) Fuel metabolism in starvation. Annu Rev Nutr 26:1–22. https://doi.org/10.1146/annurev.nutr.26.061505.111258
Chen P, Goldberg DE, Kolb B, Lanser M, Benowitz LI (2002) Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proc Natl Acad Sci USA 99(13):9031–9036. https://doi.org/10.1073/pnas.132076299
Chong J, Soufan O, Li C et al (2018) MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 46(W1):W486–W494. https://doi.org/10.1093/nar/gky310
Costa I, Carvalho F, Magalhães T, Guedes de Pinho P, Silvestre R, Dinis-Oliveira RJ (2015) Promising blood-derived biomarkers for estimation of the postmortem interval. Toxicol Res 4(6):1443–1452. https://doi.org/10.1039/c5tx00209e
Creagh S, Warden D, Latif MA, Paydar A (2018) The new classes of synthetic illicit drugs can significantly harm the brain: a neuro imaging perspective with full review of MRI findings. Clin Radiol Imaging J 2(1):000116
Dieterle F, Ross A, Schlotterbeck G, Senn H (2006) Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem 78(13):4281–4290. https://doi.org/10.1021/ac051632c
Dinis-Oliveira RJ (2014) Metabolomics of drugs of abuse: a more realistic view of the toxicological complexity. Bioanalysis 6(23):3155–3159. https://doi.org/10.4155/bio.14.260
Dores-Sousa JL, Duarte JA, Seabra V, Bastos Mde L, Carvalho F, Costa VM (2015) The age factor for mitoxantrone’s cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. Toxicology 329:106–119. https://doi.org/10.1016/j.tox.2015.01.006
Dunn WB, Wilson ID, Nicholls AW, Broadhurst D (2012) The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis 4(18):2249–2264. https://doi.org/10.4155/bio.12.204
EMCDDA (2014) EMCDDA—Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone). In: Joint Reports, Publications Office of the European Union. www.emcdda.europa.eu. Accessed 19 Jun 2020
EMCDDA (2019) European Drug Report 2019: Trends and Developments. In. www.emcdda.europa.eu Accessed 05 Jan 2020
Froberg BA, Levine M, Beuhler MC et al (2015) Acute methylenedioxypyrovalerone toxicity. J Med Toxicol 11(2):185–194. https://doi.org/10.1007/s13181-014-0446-8
Garibotto G, Sofia A, Saffioti S, Bonanni A, Mannucci I, Verzola D (2010) Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease. Clin Nutr 29(4):424–433. https://doi.org/10.1016/j.clnu.2010.02.005
Gavriilidis G, Kyriakoudi A, Tiniakos D, Rovina N, Koutsoukou A (2015) “Bath Salts” intoxication with multiorgan failure and left-sided ischemic colitis: a case report. Hippokratia 19(4):363–365
Hanna VS, Hafez EAA (2018) Synopsis of arachidonic acid metabolism: a review. J Adv Res 11:23–32. https://doi.org/10.1016/j.jare.2018.03.005
Hasko G, Kuhel DG, Nemeth ZH et al (2000) Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol 164(2):1013–1019. https://doi.org/10.4049/jimmunol.164.2.1013
Hasko G, Sitkovsky MV, Szabo C (2004) Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 25(3):152–157. https://doi.org/10.1016/j.tips.2004.01.006
Haun SE, Segeleon JE, Trapp VL, Clotz MA, Horrocks LA (1996) Inosine mediates the protective effect of adenosine in rat astrocyte cultures subjected to combined glucose-oxygen deprivation. J Neurochem 67(5):2051–2059. https://doi.org/10.1046/j.1471-4159.1996.67052051.x
Iruzubieta P, Arias-Loste MT, Barbier-Torres L, Martinez-Chantar ML, Crespo J (2015) The need for biomarkers in diagnosis and prognosis of drug-induced liver disease: does metabolomics have any role? Biomed Res Int 2015:386186. https://doi.org/10.1155/2015/386186
Irwin C, van Reenen M, Mason S, Mienie LJ, Westerhuis JA, Reinecke CJ (2016) Contribution towards a metabolite profile of the detoxification of benzoic acid through glycine conjugation: an intervention study. PLoS ONE 11(12):e0167309. https://doi.org/10.1371/journal.pone.0167309
Jaeger C, Glaab E, Michelucci A et al (2015) The mouse brain metabolome: region-specific signatures and response to excitotoxic neuronal injury. Am J Pathol 185(6):1699–1712. https://doi.org/10.1016/j.ajpath.2015.02.016
Jurkowitz MS, Litsky ML, Browning MJ, Hohl CM (1998) Adenosine, inosine, and guanosine protect glial cells during glucose deprivation and mitochondrial inhibition: correlation between protection and ATP preservation. J Neurochem 71(2):535–548. https://doi.org/10.1046/j.1471-4159.1998.71020535.x
Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48:653–683. https://doi.org/10.1146/annurev.pharmtox.48.113006.094715
Kesha K, Boggs CL, Ripple MG et al (2013) Methylenedioxypyrovalerone (“bath salts”), related death: case report and review of the literature. J Forensic Sci 58(6):1654–1659. https://doi.org/10.1111/1556-4029.12202
Koo SH (2013) Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin Mol Hepatol 19(3):210–215. https://doi.org/10.3350/cmh.2013.19.3.210
Leong HS, Philp M, Simone M, Witting PK, Fu S (2020) Synthetic cathinones induce cell death in dopaminergic SH-SY5Y cells via stimulating mitochondrial dysfunction. Int J Mol Sci. https://doi.org/10.3390/ijms21041370
Lindon JC, Holmes E, Nicholson JK (2006) Metabonomics techniques and applications to pharmaceutical research & development. Pharm Res 23(6):1075–1088. https://doi.org/10.1007/s11095-006-0025-z
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275
Lu SC (2009) Regulation of glutathione synthesis. Mol Aspects Med 30(1–2):42–59. https://doi.org/10.1016/j.mam.2008.05.005
Luethi D, Liechti ME, Krahenbuhl S (2017) Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones. Toxicology 387:57–66. https://doi.org/10.1016/j.tox.2017.06.004
Lushchak VI (2012) Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids 2012:736837. https://doi.org/10.1155/2012/736837
Ly-Verdu S, Schaefer A, Kahle M et al (2014) The impact of blood on liver metabolite profiling - a combined metabolomic and proteomic approach. Biomed Chromatogr 28(2):231–240. https://doi.org/10.1002/bmc.3010
Ma SK, Kim HY, Kim CS, Bae EH, Kim SW (2015) Serum LDH level is associated with decreased eGFR and proteinuria in patients with glomerolonephritis. Nephrol Dialysis Transplant 30(3):iii111
Manier SK, Wagmann L, Flockerzi V, Meyer MR (2020) Toxicometabolomics of the new psychoactive substances alpha-PBP and alpha-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts. Arch Toxicol 94(6):2047–2059. https://doi.org/10.1007/s00204-020-02742-1
Marton A, Pacher P, Murthy KG, Nemeth ZH, Hasko G, Szabo C (2001) Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro. Int J Mol Med 8(6):617–621
Mastrangelo A, Ferrarini A, Rey-Stolle F, Garcia A, Barbas C (2015) From sample treatment to biomarker discovery: a tutorial for untargeted metabolomics based on GC-(EI)-Q-MS. Anal Chim Acta 900:21–35. https://doi.org/10.1016/j.aca.2015.10.001
McClenahan SJ, Hambuchen MD, Simecka CM, Gunnell MG, Berquist MD, Owens SM (2019) Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats. Drug Alcohol Depend 195:140–147. https://doi.org/10.1016/j.drugalcdep.2018.12.006
Meyer MR, Du P, Schuster F, Maurer HH (2010) Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS. J Mass Spectrom 45(12):1426–1442. https://doi.org/10.1002/jms.1859
Moffatt BA, Ashihara H (2002) Purine and pyrimidine nucleotide synthesis and metabolism. Arabidopsis Book 1:e0018. https://doi.org/10.1199/tab.0018
Motulsky HJ, Brown RE (2006) Detecting outliers when fitting data with nonlinear regression—a new method based on robust nonlinear regression and the false discovery rate. BMC Bioinform 7:123. https://doi.org/10.1186/1471-2105-7-123
Murray BL, Murphy CM, Beuhler MC (2012) Death following recreational use of designer drug “bath salts” containing 3,4-Methylenedioxypyrovalerone (MDPV). J Med Toxicol 8(1):69–75. https://doi.org/10.1007/s13181-011-0196-9
Novellas J, Lopez-Arnau R, Carbo ML, Pubill D, Camarasa J, Escubedo E (2015) Concentrations of MDPV in rat striatum correlate with the psychostimulant effect. J Psychopharmacol 29(11):1209–1218. https://doi.org/10.1177/0269881115598415
Perrine SA, Michaels MS, Ghoddoussi F, Hyde EM, Tancer ME, Galloway MP (2009) Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat. NMR Biomed 22(4):419–425. https://doi.org/10.1002/nbm.1352
Pluskal T, Castillo S, Villar-Briones A, Oresic M (2010) MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform 11:395. https://doi.org/10.1186/1471-2105-11-395
Prosser JM, Nelson LS (2012) The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 8(1):33–42. https://doi.org/10.1007/s13181-011-0193-z
Ramirez T, Daneshian M, Kamp H et al (2013) Metabolomics in toxicology and preclinical research. Altex 30(2):209–225. https://doi.org/10.14573/altex.2013.2.209
Rosas-Hernandez H, Cuevas E, Lantz SM et al (2016) 3,4-methylenedioxypyrovalerone (MDPV) induces cytotoxic effects on human dopaminergic SH-SY5Y cells. J Drug Alcohol Res 5:1–6
Rui L (2014) Energy metabolism in the liver. Compr Physiol 4(1):177–197. https://doi.org/10.1002/cphy.c130024
Smith L, Villaret-Cazadamont J, Claus SP et al (2020) Important considerations for sample collection in metabolomics studies with a special focus on applications to liver functions. Metabolites. https://doi.org/10.3390/metabo10030104
Steuer AE, Brockbals L, Kraemer T (2019) Metabolomic strategies in biomarker research-new approach for indirect identification of drug consumption and sample manipulation in clinical and forensic toxicology? Front Chem 7:319. https://doi.org/10.3389/fchem.2019.00319
Sumner LW, Amberg A, Barrett D et al (2007) Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3(3):211–221. https://doi.org/10.1007/s11306-007-0082-2
Tallima H, El Ridi R (2018) Arachidonic acid: physiological roles and potential health benefits—a review. J Adv Res 11:33–41. https://doi.org/10.1016/j.jare.2017.11.004
Tarkowski P, Jankowski K, Budzynska B, Biala G, Boguszewska-Czubara A (2018) Potential pro-oxidative effects of single dose of mephedrone in vital organs of mice. Pharmacol Rep 70(6):1097–1104. https://doi.org/10.1016/j.pharep.2018.05.010
Valente MJ, Guedes de Pinho P, de Lourdes BM, Carvalho F, Carvalho M (2014) Khat and synthetic cathinones: a review. Arch Toxicol 88(1):15–45. https://doi.org/10.1007/s00204-013-1163-9
Valente MJ, Araujo AM, Bastos Mde L et al (2016) Editor’s highlight: characterization of hepatotoxicity mechanisms triggered by designer Cathinone drugs (beta-Keto Amphetamines). Toxicol Sci 153(1):89–102. https://doi.org/10.1093/toxsci/kfw105
Valente MJ, Araujo AM, Silva R et al (2016) 3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions. Arch Toxicol 90(8):1959–1973. https://doi.org/10.1007/s00204-015-1653-z
Valente MJ, Amaral C, Correia-da-Silva G et al (2017) Methylone and MDPV activate autophagy in human dopaminergic SH-SY5Y cells: a new insight into the context of beta-keto amphetamines-related neurotoxicity. Arch Toxicol 91(11):3663–3676. https://doi.org/10.1007/s00204-017-1984-z
Valente MJ, Bastos ML, Fernandes E, Carvalho F, Guedes de Pinho P, Carvalho M (2017) Neurotoxicity of beta-Keto amphetamines: deathly mechanisms elicited by methylone and MDPV in human dopaminergic SH-SY5Y cells. ACS Chem Neurosci 8(4):850–859. https://doi.org/10.1021/acschemneuro.6b00421
Valsalan R, Varghese B, Soman D, Buckmaster J, Yew S, Cooper D (2017) Multi-organ dysfunction due to bath salts: are we aware of this entity? Intern Med J 47(1):109–111. https://doi.org/10.1111/imj.13307
Vaz I, Carvalho T, Valente MJ et al (2020) The interplay between autophagy and apoptosis mediates toxicity triggered by synthetic cathinones in human kidney cells. Toxicol Lett 331:42–52. https://doi.org/10.1016/j.toxlet.2020.05.025
Vincent IM, Ehmann DE, Mills SD, Perros M, Barrett MP (2016) Untargeted metabolomics to ascertain antibiotic modes of action. Antimicrob Agents Chemother 60(4):2281–2291. https://doi.org/10.1128/AAC.02109-15
Wang P, Wu YJ (2015) Applications of metabonomics in pesticide toxicology. Curr Drug Metab 16(3):191–199. https://doi.org/10.2174/138920021603150812121002
Want EJ, Masson P, Michopoulos F et al (2013) Global metabolic profiling of animal and human tissues via UPLC-MS. Nat Protoc 8(1):17–32. https://doi.org/10.1038/nprot.2012.135
Welihinda AA, Kaur M, Greene K, Zhai Y, Amento EP (2016) The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias. Cell Signal 28(6):552–560. https://doi.org/10.1016/j.cellsig.2016.02.010
Wheelock AM, Wheelock CE (2013) Trials and tribulations of ’omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine. Mol Biosyst 9(11):2589–2596. https://doi.org/10.1039/c3mb70194h
Worley B, Powers R (2013) Multivariate analysis in metabolomics. Curr Metabol 1(1):92–107. https://doi.org/10.2174/2213235X11301010092
Wu Y, Li L (2016) Sample normalization methods in quantitative metabolomics. J Chromatogr A 1430:80–95. https://doi.org/10.1016/j.chroma.2015.12.007
Wyman JF, Lavins ES, Engelhart D et al (2013) Postmortem tissue distribution of MDPV following lethal intoxication by “bath salts.” J Anal Toxicol 37(3):182–185. https://doi.org/10.1093/jat/bkt001
Xiong Z, Wang Y, Lang L et al (2018) Tissue metabolomic profiling to reveal the therapeutic mechanism of reduning injection on LPS-induced acute lung injury rats. RSC Adv. https://doi.org/10.1039/c7ra13123b
Yang H, Shan W, Zhu F, Wu J, Wang Q (2019) Ketone bodies in neurological diseases: focus on neuroprotection and underlying mechanisms. Front Neurol 10:585. https://doi.org/10.3389/fneur.2019.00585
Zaitsu K, Hayashi Y, Kusano M, Tsuchihashi H, Ishii A (2016) Application of metabolomics to toxicology of drugs of abuse: a mini review of metabolomics approach to acute and chronic toxicity studies. Drug Metab Pharmacokinet 31(1):21–26. https://doi.org/10.1016/j.dmpk.2015.10.002
Zhang A, Sun H, Wang P, Han Y, Wang X (2012) Modern analytical techniques in metabolomics analysis. Analyst 137(2):293–300. https://doi.org/10.1039/c1an15605e
Zhang A, Sun H, Yan G, Wang P, Wang X (2016) Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research. Biomed Chromatogr 30(1):7–12. https://doi.org/10.1002/bmc.3453
Acknowledgements
This work was supported by the Applied Molecular Biosciences Unit—UCIBIO which is financed by national funds from FCT (UIDB/04378/2020). A. M. Araújo thanks to FCT for her Ph.D. fellowship (SFRH/BD/107708/2015). VMC acknowledges her grant (SFRH/BHD/110001/2015), received by Portuguese national funds through Fundação para a Ciência e Tecnologia (FCT), IP, under the Norma Transitória DL57/2016/CP1334/CT0006.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing financial interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Araújo, A.M., Carvalho, M., Costa, V.M. et al. In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV). Arch Toxicol 95, 509–527 (2021). https://doi.org/10.1007/s00204-020-02949-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-020-02949-2